New Drug on PBS for Chronic Kidney Disease Patients
Epworth Nephrologist, Professor Ian Fraser welcomed the Hon. Greg Hunt, Minister for Health, to Epworth Richmond on Thursday 20 December 2018 for the Federal government announcement of the drug Tolvaptan (Brand name Jinarc) being put on the PBS.
A number of families affected by genetic kidney disease were present to welcome the announcement that would save them around $23,000 per year and help them live a healthier life.
Trial investigator Professor Fraser said that the drug’s effectiveness has been established during the last ten years in two key global studies with Epworth being the number one recruiting site in Australia in both studies.
“For young adults with this condition, this is a breakthrough. This is the first drug which has been proven to be of benefit in the inherited condition, Autosomal Dominant Polycystic Kidney Disease (APKD). APKD effects over one in a thousand people, and commonly leads to kidney failure and dialysis in the mid 50s,” Professor Fraser said.
You can read more about the announcement by Minister Hunt here.
Photo by DS Images.
We know that staying on top of your weight can sometimes seem like an overwhelming task. Here’s some things to consider when trying to maintain a healthy body weight.
If you look closely, you will see them on people’s wrists everywhere. Smart watches or fitness trackers claim to count your steps, measure your sleep, calculate calories, document your heart rate, and now, some even test your heart function with an ECG.
Trying to keep on top of your health at work can be a trying task. Here’s some tips we suggest so you can perform at your best.
London called and it called loudly at the Epworth HealthCare Gala Ball on Saturday 3 August.
Serving up more than 3,000 meals a day with a culinary experience you’d expect at a luxury hotel, it’s no surprises that Epworth Richmond has been recognised for excellence in its room service program.